3 completed. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow OPC-67683: new trials by email Literature Review of OPC-67683 trials Research Report on OPC-67683
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in Children With MDR-TB With and Without HIV Delamanid, Optimized multidrug background regimen (OBR) for children with MDR-TB - Tuberculosis, HIV Infections | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 37 | 2019-02-18 | 2026-06-25 |
| A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis 10 mg OPC-167832, 30 mg OPC-167832, 90 mg OPC-167832 - Pulmonary TB | Phase 1 / Phase 2 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 122 | 2018-10-18 | 2023-11-18 |
| Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis 100 mg Delamanid, 50 mg Delamanid, 25 mg Pediatric Formulation Delamanid - Multidrug Resistant Tuberculosis, Pediatric | Phase 1 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 37 | 2013-06-14 | 2018-01-30 |
Tuberculosis (2) · Actinomycetales Infections (1) · Bacterial Infections (1) · HIV Infections (1) · Mycobacterium Infections (1) · Tuberculosis, Multidrug-Resistant (1) · Tuberculosis, Pulmonary (1)
Otsuka Pharmaceutical Development & Commercialization, Inc. (2) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
South Africa (3) · India (1) · Philippines (1) · Tanzania (1)
Anthony Garcia-Prats, MD (1) · Ethel Weld, MD (1) · Jeffrey Hafkin, MD (1) · Prof. Andreas Diacon (1) · Prof. Rodney Dawson, MD (1) · Veronique R de Jager, MD (1)